Ian F. Smith

2011

In 2011, Ian F. Smith earned a total compensation of $3.3M as EVP & Chief Financial Officer at Vertex Pharmaceuticals, a 7% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$425,493
Option Awards$1,914,319
Salary$523,535
Stock Awards$468,738
Other$12,495
Total$3,344,580

Smith received $1.9M in option awards, accounting for 57% of the total pay in 2011.

Smith also received $425.5K in non-equity incentive plan, $523.5K in salary, $468.7K in stock awards and $12.5K in other compensation.

Rankings

In 2011, Ian F. Smith's compensation ranked 1,846th out of 10,747 executives tracked by ExecPay. In other words, Smith earned more than 82.8% of executives.

ClassificationRankingPercentile
All
1,846
out of 10,747
83rd
Division
Manufacturing
672
out of 3,958
83rd
Major group
Chemicals And Allied Products
143
out of 1,031
86th
Industry group
Drugs
80
out of 779
90th
Industry
Pharmaceutical Preparations
67
out of 567
88th
Source: SEC filing on March 28, 2014.

Smith's colleagues

We found four more compensation records of executives who worked with Ian F. Smith at Vertex Pharmaceuticals in 2011.

2011

Matthew Emmens

Vertex Pharmaceuticals

Chief Executive Officer

2011

Jeffrey Leiden

Vertex Pharmaceuticals

Chief Executive Officer

2011

Peter Mueller

Vertex Pharmaceuticals

Chief Scientific Officer

2011

Nancy Wysenski

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

News

In-depth

You may also like